These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1638777)

  • 21. [Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study].
    Romics L; Karádi I; Csanády M; Gógl A; Jánosi A; Ofner P; Tarján J; Varga L; Wórum F; Zeltner G
    Orv Hetil; 1994 Oct; 135(40):2187-91. PubMed ID: 7970631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
    van Deursen RT; Nieuwenhuijzen Kruseman AC; Degenaar CP; Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2142-6. PubMed ID: 2247172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individual responsiveness to a cholesterol-lowering diet in postmenopausal women with moderate hypercholesterolemia.
    Denke MA
    Arch Intern Med; 1994 Sep; 154(17):1977-82. PubMed ID: 8074602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits.
    Tijerina O; Dombrovskis S; Esper E; Matts JP; Campos CT; Buchwald H
    Surgery; 1988 Oct; 104(4):796-805. PubMed ID: 3175875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lovastatin. A new drug for the treatment of hypercholesterolemia].
    Abouganem D; Núñez P
    Rev Med Panama; 1990 Sep; 15(3):184-96. PubMed ID: 2284448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
    Agrawal AR; Tandon M; Sharma PL
    Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria.
    Golper TA; Illingworth DR; Morris CD; Bennett WM
    Am J Kidney Dis; 1989 Apr; 13(4):312-20. PubMed ID: 2650539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome.
    Kasiske BL; Velosa JA; Halstenson CE; La Belle P; Langendörfer A; Keane WF
    Am J Kidney Dis; 1990 Jan; 15(1):8-15. PubMed ID: 2294737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism.
    Vega GL; Grundy SM
    Kidney Int; 1988 Jun; 33(6):1160-8. PubMed ID: 3165483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus.
    Goldberg R; La Belle P; Zupkis R; Ronca P
    Am J Cardiol; 1990 Sep; 66(8):16B-21B. PubMed ID: 2206032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein level following treatment and withdrawal of lovastatin in diabetic nephropathy.
    Rashtchizadeh N; Argani H; Ghorbanihaghjo A; Nezami N; Safa J; Montazer-Saheb S
    Iran J Kidney Dis; 2009 Apr; 3(2):93-8. PubMed ID: 19395785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lovastatin in the treatment of hypercholesterolemia in CAPD.
    Krane NK; Stock G; Caballero M; Starks E
    Adv Perit Dial; 1992; 8():362-4. PubMed ID: 1361823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effectiveness of lovastatin therapy for hypercholesterolemia after heart transplantation between patients with and without pretransplant atherosclerotic coronary artery disease.
    Anguita M; Alonso-Pulpón L; Arizón JM; Cavero MA; Vallés F; Segovia J; Pérez-Jiménez F; Crespo M; Concha M
    Am J Cardiol; 1994 Oct; 74(8):776-9. PubMed ID: 7942548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets.
    Cobb MM; Teitelbaum HS; Breslow JL
    JAMA; 1991 Feb; 265(8):997-1001. PubMed ID: 1992214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of lovastatin on the development of adriamycin nephropathy in rats].
    Tesar V; Zima T; Poledne R; Stejskalová A; Tĕmínová J; Stípek S
    Sb Lek; 1995; 96(1):35-42. PubMed ID: 8711364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Am J Cardiol; 1993 Jan; 71(1):82-7. PubMed ID: 8093585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of supplemental dietary fat on plasma cholesterol levels in lovastatin-treated hypercholesterolemic patients.
    McKenney JM; Proctor JD; Wright JT; Kolinski RJ; Elswick RK; Coaker JS
    Pharmacotherapy; 1995; 15(5):565-72. PubMed ID: 8570427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.
    Gholamin S; Razavi SM; Taghavi-Garmestani SM; Ghorbanihaghjo A; Rashtchizadeh N; Safa J; Vatankhah AM; Azizi T; Argani H
    Iran J Kidney Dis; 2014 May; 8(3):201-6. PubMed ID: 24878942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of dyslipidemia in non-insulin-dependent diabetes mellitus with lovastatin.
    Garg A; Grundy SM
    Am J Cardiol; 1988 Nov; 62(15):44J-49J. PubMed ID: 3055923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lovastatin therapy and withdrawal on serum uric acid level in people with type 2 diabetic nephropathy.
    Nezami N; Safa J; Salari B; Ghorashi S; Khosraviani K; Davari-Farid S; Hashemi-Aghdam Y; Nargabad ON; Tabrizi JS
    Nucleosides Nucleotides Nucleic Acids; 2012 Apr; 31(4):353-63. PubMed ID: 22444196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.